May 20, 2021
On-Demand Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products
April 12, 2021
Certus PV, a Veristat Company experts recently lead an Xtalks webinar - View it On-Demand Now
Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.
October 12, 2020
View the On-Demand Webinar
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.